Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Dual-Monochromator Scanning Fluorescence Spectrometer

By Drug Discovery Trends Editor | July 7, 2010

Thermo Scientific Lumina


Thermo Fisher Scientific Inc. launched the Thermo Scientific Lumina, a research-grade dual-monochromator scanning fluorescence spectrometer that offers a new level of clarity in fluorescence measurement. Designed for both demanding research applications and routine laboratory analysis, the Lumina delivers 0.5 nm spectral bandwidth, high sensitivity and fast scanning speed, providing rapid and accurate assay development, quantification and sample analysis applications in life science, QA/QC, materials science, pharmaceutical, environmental, photochemistry and luminescence laboratories.


With its ability to provide 0.5 nm spectral bandwidth, the spectrometer offers superior resolving power when compared with competitive systems in the same price range, enabling analysts to uncover the most detailed information about their samples, including sample features that are closely positioned, and better discriminate between peaks in spectra. Additionally, the increased sensitivity offers the advantages of lower limits of detection, less noise and more consistent baseline measurements.


The powerful xenon lamp in the spectrometer, combined with optimized monochromators, allows for the detection of sample concentrations below parts-per-billion levels for compounds such as harmful heavy metals, polycyclic aromatic hydrocarbons and more. A fast, accurate and reliable monochromator drive mechanism enables slewing at 20,000 nm/min and wavelength scanning at speeds of up to 6,000 nm/min. This reduces the exposure of photosensitive samples during synchronous and 3D scanning experiments. The instrument’s photomultiplier detector offers extended measurement of the near-infrared wavelength (190 nm to 900 nm), which facilitates cutting-edge research in biochemistry and photosynthesis applications.


With a large sample compartment and a wide range of accessories for temperature control, polarization and solid sample measurement, the spectrometer can be expanded for use in a variety of applications. The instrument uses Thermo Scientific Luminous software for complete instrument and accessory control, as well as efficient data collection, analysis and reporting.


Thermo Fisher Scientific Inc. 


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50